NEET-UG Re-exam Prep: India’s National Medical Commission told medical colleges to stay vigilant and not grant leave to students on June 20–21, aiming to protect the exam’s integrity. Public Health Access Gap: Kurdistan’s civic health report says only 4% of patients get medications through public institutions; 96% end up buying from the open market, with cancer and psychiatric patients hit hardest. Regulation & Oversight: Louisiana is tightening Medicaid provider oversight with more frequent reviews, expanded verification, and stronger monitoring for high-risk categories. Drug Pricing & Trade: The U.S. launched a Section 301 probe into Germany’s pharma pricing, alleging persistent underpayment for innovative medicines and possible unfair practices. Cancer Treatment Update: Sanofi’s Sarclisa got Japan approval for a subcutaneous multiple myeloma regimen, including combinations for relapsed and newly diagnosed patients. Medical Devices Digitization: Bahrain’s NHRA rolled out systems to register and track medical devices and supplies, boosting traceability and patient safety. Healthcare Business Watch: Alembic Pharmaceuticals received tentative U.S. FDA approval for a generic binimetinib tablet, targeting a cancer drug market.